Skip directly to content

Supporting Australian Scientists

Pfizer Australia is a heavy investor in Australian-based medical research and development (R&D). Between 2005 and 2015, Pfizer’s Worldwide Research and Development has funded approximately $90 million in R&D projects in Australia (excluding matching funding and the cost of clinical trials). 

In 2014, Pfizer Australia awarded three Australasian Pediatric Endocrine Care (APEC) Research Grants of $50K each to the best and brightest researchers in pediatric endocrinology.